{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:10:03Z","timestamp":1788815403464,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Thyroid cancer mortality has varied across demographic groups in the US, but comprehensive recent analyses are limited. This population-based retrospective cohort study examines trends in thyroid cancer-related mortality from 1999 to 2023 using data from the Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research (CDC WONDER).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Mortality due to malignant thyroid neoplasms (ICD-10 C73) was included. Eligibility included US resident deaths recorded between 1999 and 2023 with thyroid cancer as the underlying cause. Trends in age-adjusted mortality rates (AAMR, per 100,000) across sex, age, race\/ethnicity, urbanization, and geographic regions were analyzed using Joinpoint regression with Monte Carlo permutation to estimate annual percent change (APC) and average annual percentage changes (AAPC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During the study period, 53,145 deaths were attributed to malignant neoplasms of the thyroid. The overall AAMR declined from 0.86 to 0.77 per 100,000. Both sexes showed increased mortality until about 2019 and 2020, following which there were significant declines in mortality. Male patients experienced a higher mortality increase pre-2020 and steeper decline post-2020. Rural populations observed greater mortality increases compared to urban populations. Black or African American patients and White patients had consistently lower thyroid cancer-related mortality than Asian or Pacific Islander and Hispanic patients. Asian or Pacific Islander patients demonstrated relatively stable AAMRs over the study period without a statistically significant change. Older age groups, especially\u2009\u2265\u200985 years, had the highest crude mortality and significant increase in mortality post-2017. The South, Midwest, and West regions had significant mortality increases with a sharp rise in the South post-2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite an overall decline in malignant thyroid neoplasm related mortality since 1999, there are persistent disparities due to sex, age, urbanization, race and region. Future research should investigate the drivers of the disparities closely, and healthcare policy should also aim to improve availability and accessibility to thyroid cancer related education, screening, detection, and treatment especially to those populations with disproportionately high risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12902-026-02402-y","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T02:06:39Z","timestamp":1783389999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends and disparities in thyroid cancer related mortality from 1999 to 2023: a CDC WONDER database analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Reesha","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Ung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abubakar","family":"Tauseef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"issue":"3","key":"2402_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"2402_CR2","unstructured":"National Cancer Institute. Thyroid cancer\u2014cancer stat facts [Internet]. 2024 [cited 2025 May 7]. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/thyro.html"},{"issue":"2","key":"2402_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1089\/thy.2010.0190","volume":"21","author":"B Aschebrook-Kilfoy","year":"2011","unstructured":"Aschebrook-Kilfoy B, Ward MH, Sabra MM, Devesa SS. Thyroid cancer incidence patterns in the United States by histologic type, 1992\u20132006. Thyroid. 2011;21(2):125\u201334. https:\/\/doi.org\/10.1089\/thy.2010.0190.","journal-title":"Thyroid"},{"issue":"5","key":"2402_CR4","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359\u201386. https:\/\/doi.org\/10.1002\/ijc.29210.","journal-title":"Int J Cancer"},{"issue":"11","key":"2402_CR5","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nrendo.2016.110","volume":"12","author":"CM Kitahara","year":"2016","unstructured":"Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016;12(11):646\u201353. https:\/\/doi.org\/10.1038\/nrendo.2016.110.","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"2402_CR6","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1667\/RR3318.1","volume":"163","author":"CE Land","year":"2005","unstructured":"Land CE, Bouville A, Ron E. Thyroid cancer risk in populations exposed to environmental radiation from the Chernobyl accident. Radiat Res. 2005;163(5):717\u201320. https:\/\/doi.org\/10.1667\/RR3318.1.","journal-title":"Radiat Res"},{"issue":"7","key":"2402_CR7","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1210\/jc.2017-00358","volume":"102","author":"JH Lubin","year":"2017","unstructured":"Lubin JH, Adams MJ, Shore R, Holmberg E, Schneider AB, Hawkins MM, et al. Thyroid cancer following childhood low-dose radiation exposure: a pooled analysis of nine studies. J Clin Endocrinol Metab. 2017;102(7):2575\u201383. https:\/\/doi.org\/10.1210\/jc.2017-00358.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2402_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1667\/RR14213.1","volume":"185","author":"LH Veiga","year":"2016","unstructured":"Veiga LH, Holmberg E, Anderson H, Pottern LM, Sadetzki S, Ron E, et al. Thyroid cancer after childhood exposure to external radiation: an updated pooled analysis of 12 studies. Radiat Res. 2016;185(5):473\u201384. https:\/\/doi.org\/10.1667\/RR14213.1.","journal-title":"Radiat Res"},{"issue":"3","key":"2402_CR9","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.ecl.2017.03.010","volume":"46","author":"RE Shore","year":"2017","unstructured":"Shore RE. Radiation-induced thyroid cancer: what we have learned from epidemiology. Endocrinol Metab Clin North Am. 2017;46(3):593\u2013611. https:\/\/doi.org\/10.1016\/j.ecl.2017.03.010.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"7","key":"2402_CR10","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1289\/ehp.1002674","volume":"119","author":"AV Brenner","year":"2011","unstructured":"Brenner AV, Tronko MD, Hatch M, Bogdanova TI, Oliynyk VA, Lubin JH, et al. Iodine-131 dose-response for incident thyroid cancers in Ukraine related to the Chornobyl accident. Environ Health Perspect. 2011;119(7):933\u20139. https:\/\/doi.org\/10.1289\/ehp.1002674.","journal-title":"Environ Health Perspect"},{"issue":"12","key":"2402_CR11","first-page":"5268","volume":"7","author":"W Zhang","year":"2014","unstructured":"Zhang W, Bai X, Ge H, Cui H, Wei Z, Han G. Meta-analysis in the association between obesity and risk of thyroid cancer. Int J Clin Exp Med. 2014;7(12):5268\u201374.","journal-title":"Int J Clin Exp Med"},{"key":"2402_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.12659\/MSM.892035","volume":"21","author":"J Ma","year":"2015","unstructured":"Ma J, Huang M, Wang L, Ye W, Tong Y, Wang H. Obesity and risk of thyroid cancer: evidence from a meta-analysis of 21 observational studies. Med Sci Monit. 2015;21:283\u201391. https:\/\/doi.org\/10.12659\/MSM.892035.","journal-title":"Med Sci Monit"},{"issue":"11","key":"2402_CR13","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1001\/archoto.2011.194","volume":"137","author":"A Kamat","year":"2011","unstructured":"Kamat A, Rajoria S, George A, et al. Estrogen-mediated angiogenesis in thyroid tumor microenvironment is mediated through VEGF signaling pathways. Arch Otolaryngol Head Neck Surg. 2011;137(11):1146\u201353. https:\/\/doi.org\/10.1001\/archoto.2011.194.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"1","key":"2402_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1089\/thy.2009.0296","volume":"20","author":"S Rajoria","year":"2010","unstructured":"Rajoria S, Suriano R, Shanmugam A, et al. Metastatic phenotype is regulated by estrogen in thyroid cells. Thyroid. 2010;20(1):33\u201341. https:\/\/doi.org\/10.1089\/thy.2009.0296.","journal-title":"Thyroid"},{"issue":"1","key":"2402_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12902-024-01670-w","volume":"24","author":"Y Le","year":"2024","unstructured":"Le Y, Geng C, Gao X, Zhang P. The risk of thyroid cancer and sex differences in Hashimoto\u2019s thyroiditis, a meta-analysis. BMC Endocr Disord. 2024;24(1):151. https:\/\/doi.org\/10.1186\/s12902-024-01670-w.","journal-title":"BMC Endocr Disord"},{"issue":"5","key":"2402_CR16","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1089\/thy.2021.0662","volume":"32","author":"UC Megwalu","year":"2022","unstructured":"Megwalu UC, Moon PK. Thyroid cancer incidence and mortality trends in the United States: 2000\u20132018. Thyroid. 2022;32(5):560\u201370. https:\/\/doi.org\/10.1089\/thy.2021.0662.","journal-title":"Thyroid"},{"issue":"4","key":"2402_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1001\/jamaoto.2014.3740","volume":"141","author":"A Magreni","year":"2015","unstructured":"Magreni A, Bann DV, Schubart JR, Goldenberg D. The effects of race and ethnicity on thyroid cancer incidence. JAMA Otolaryngol Head Neck Surg. 2015;141(4):319\u201323. https:\/\/doi.org\/10.1001\/jamaoto.2014.3740.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"16","key":"2402_CR18","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.3390\/cancers15164102","volume":"15","author":"A Al-Ibraheem","year":"2023","unstructured":"Al-Ibraheem A, Al-Rasheed U, Mashhadani N, Abdlkadir AS, Al-Adhami DA, Ruzzeh S, et al. Long-term survival analysis and prognostic factors of Arabic patients with differentiated thyroid carcinoma: a 20-year observational study at the King Hussein Cancer Center (KHCC) involving 528 patients. Cancers. 2023;15(16):4102. https:\/\/doi.org\/10.3390\/cancers15164102.","journal-title":"Cancers"},{"issue":"5","key":"2402_CR19","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1089\/thy.2008.0281","volume":"20","author":"GP Yu","year":"2010","unstructured":"Yu GP, Li JC, Branovan D, McCormick S, Schantz SP. Thyroid cancer incidence and survival in the National Cancer Institute Surveillance, Epidemiology, and End Results race\/ethnicity groups. Thyroid. 2010;20(5):465\u201373. https:\/\/doi.org\/10.1089\/thy.2008.0281.","journal-title":"Thyroid"},{"key":"2402_CR20","doi-asserted-by":"crossref","unstructured":"Mohamed AA, Samantha T, Terry H, Randall PS, Sanziana AR, Julia AS. Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems. J Clin Oncol. 2016;34:4415\u201320. https:\/\/doi.org\/10.1200\/JCO.2016.68.9372.","DOI":"10.1200\/JCO.2016.68.9372"},{"key":"2402_CR21","unstructured":"Centers for Disease Control and Prevention. Multiple cause of death data on CDC WONDER [Internet]. 2025 [cited 2025 May 7]. Available from: https:\/\/wonder.cdc.gov\/mcd.html"},{"issue":"9","key":"2402_CR22","doi-asserted-by":"publisher","first-page":"e02515","DOI":"10.1016\/j.heliyon.2019.e02515","volume":"5","author":"D Gillis","year":"2019","unstructured":"Gillis D, Edwards BPM. The utility of Joinpoint regression for estimating population parameters given changes in population structure. Heliyon. 2019;5(9):e02515. https:\/\/doi.org\/10.1016\/j.heliyon.2019.e02515.","journal-title":"Heliyon"},{"issue":"13","key":"2402_CR23","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jama.2017.2719","volume":"317","author":"H Lim","year":"2017","unstructured":"Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in thyroid cancer incidence and mortality in the United States, 1974\u20132013. JAMA. 2017;317(13):1338\u201348. https:\/\/doi.org\/10.1001\/jama.2017.2719.","journal-title":"JAMA"},{"issue":"6","key":"2402_CR24","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1210\/clinem\/dgaa121","volume":"105","author":"KL Yan","year":"2020","unstructured":"Yan KL, Li S, Tseng CH, Kim J, Nguyen DT, Dawood NB, et al. Rising incidence and incidence-based mortality of thyroid cancer in California, 2000\u20132017. J Clin Endocrinol Metab. 2020;105(6):1770\u20137. https:\/\/doi.org\/10.1210\/clinem\/dgaa121.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2402_CR25","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.3390\/curroncol31060263","volume":"31","author":"ML Lee","year":"2024","unstructured":"Lee ML, Megwalu UC, Finegersh A, Noel JE, Chen MM. Impact of the COVID-19 pandemic on thyroid cancer surgery. Curr Oncol. 2024;31(6):3579\u201390. https:\/\/doi.org\/10.3390\/curroncol31060263.","journal-title":"Curr Oncol"},{"issue":"23","key":"2402_CR26","doi-asserted-by":"publisher","first-page":"12992","DOI":"10.3390\/ijms222312992","volume":"22","author":"V Suteau","year":"2021","unstructured":"Suteau V, Munier M, Briet C, Rodien P. Sex bias in differentiated thyroid cancer. Int J Mol Sci. 2021;22(23):12992. https:\/\/doi.org\/10.3390\/ijms222312992.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2402_CR27","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1089\/thy.2023.0357","volume":"34","author":"HH Huston-Paterson","year":"2024","unstructured":"Huston-Paterson HH, Mao Y, Tseng CH, Kim J, Bobanga I, Wu JX, et al. Rural-urban disparities in the continuum of thyroid cancer care: analysis of 92,794 cases. Thyroid. 2024;34(5):635\u201345. https:\/\/doi.org\/10.1089\/thy.2023.0357.","journal-title":"Thyroid"},{"key":"2402_CR28","unstructured":"Turrini G, Branham DK, Chen L, Conmy AB, Chappel AR, De Lew N, et al. Access to affordable care in rural America: current trends and key challenges. Assistant Secretary for Planning and Evaluation Office of Health Policy; 2021."},{"key":"2402_CR29","doi-asserted-by":"publisher","unstructured":"Crowley RJ, Lally JS, Kline DM, Bunting AM. Geographic disparities in access to oncologists and association with cancer outcomes in the United States. J Cancer Policy. 2026;100704. https:\/\/doi.org\/10.1016\/j.jcpo.2026.100704.","DOI":"10.1016\/j.jcpo.2026.100704"},{"issue":"2","key":"2402_CR30","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1245\/s10434-024-16569-y","volume":"32","author":"P Fwelo","year":"2025","unstructured":"Fwelo P, Li R, Heredia NI, Nyachoti D, Adekunle TE, Adekunle TB, et al. Disparities in thyroid cancer mortality across racial and ethnic groups: assessing the impact of socioeconomic, clinicopathologic, and treatment variations. Ann Surg Oncol. 2025;32(2):1158\u201375. https:\/\/doi.org\/10.1245\/s10434-024-16569-y.","journal-title":"Ann Surg Oncol"},{"key":"2402_CR31","doi-asserted-by":"publisher","first-page":"117955141986619","DOI":"10.1177\/1179551419866196","volume":"12","author":"A Asban","year":"2019","unstructured":"Asban A, Chung SK, Xie R, Lindeman BM, Balentine CJ, Kirklin JK, et al. Gender and racial disparities in survival after surgery among papillary and patients with follicular thyroid cancer: a 45-year experience. Clin Med Insights Endocrinol Diabetes. 2019;12:1179551419866196. https:\/\/doi.org\/10.1177\/1179551419866196.","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"2402_CR32","doi-asserted-by":"publisher","first-page":"1133098","DOI":"10.3389\/fendo.2023.1133098","volume":"14","author":"L Xu","year":"2023","unstructured":"Xu L, Cao ZX, Weng X, Wang CF. Global thyroid cancer incidence trend and age-period-cohort model analysis based on Global Burden of Disease Study from 1990 to 2019. Front Endocrinol. 2023;14:1133098. https:\/\/doi.org\/10.3389\/fendo.2023.1133098.","journal-title":"Front Endocrinol"},{"issue":"3","key":"2402_CR33","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.critrevonc.2008.02.002","volume":"67","author":"JE Zeber","year":"2008","unstructured":"Zeber JE, Copeland LA, Hosek BJ, Karnad AB, Lawrence VA, Sanchez-Reilly SE. Cancer rates, medical comorbidities, and treatment modalities in the oldest patients. Crit Rev Oncol Hematol. 2008;67(3):237\u201342. https:\/\/doi.org\/10.1016\/j.critrevonc.2008.02.002.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"2402_CR34","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/annonc\/mdu540","volume":"26","author":"C Handforth","year":"2015","unstructured":"Handforth C, Clegg A, Young C, et al. The prevalence and outcomes of frailty in older cancer patients: a systematic review. Ann Oncol. 2015;26(6):1091\u2013101. https:\/\/doi.org\/10.1093\/annonc\/mdu540.","journal-title":"Ann Oncol"},{"issue":"2","key":"2402_CR35","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/oby.20963","volume":"23","author":"CA Myers","year":"2015","unstructured":"Myers CA, Slack T, Martin CK, Broyles ST, Heymsfield SB. Regional disparities in obesity prevalence in the United States: a spatial regime analysis. Obes (Silver Spring). 2015;23(2):481\u20137. https:\/\/doi.org\/10.1002\/oby.20963.","journal-title":"Obes (Silver Spring)"},{"issue":"3","key":"2402_CR36","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1089\/thy.2013.0257","volume":"24","author":"R Udelsman","year":"2014","unstructured":"Udelsman R, Zhang Y. The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds. Thyroid. 2014;24(3):472\u20139. https:\/\/doi.org\/10.1089\/thy.2013.0257.","journal-title":"Thyroid"},{"issue":"6","key":"2402_CR37","doi-asserted-by":"publisher","first-page":"998","DOI":"10.4158\/EP13046.OR","volume":"19","author":"J Rose","year":"2013","unstructured":"Rose J, Wertheim BC, Guerrero MA. Regional differences in thyroid cancer presentation and survival: a SEER study. Endocr Pract. 2013;19(6):998\u20131006. https:\/\/doi.org\/10.4158\/EP13046.OR.","journal-title":"Endocr Pract"},{"key":"2402_CR38","unstructured":"Kheng M, Manzella A, Laird AM, Beninato T. Regional differences in thyroidectomy volume patterns across the United States [abstract]. In: Academic Surgical Congress 2025 Abstracts. Posted May 12, 2025. Abstract 47.04."},{"issue":"3","key":"2402_CR39","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/diseases12030062","volume":"12","author":"I Hassan","year":"2024","unstructured":"Hassan I, Hassan L, Bacha F, Al Salameh M, Gatee O, Hassan W. Papillary thyroid cancer trends in the wake of the COVID-19 pandemic: is there a shift toward a more aggressive entity? Diseases. 2024;12(3):62. https:\/\/doi.org\/10.3390\/diseases12030062.","journal-title":"Diseases"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02402-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02402-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02402-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:03:19Z","timestamp":1788814999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02402-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2402"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02402-y","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This study used publicly available, de-identified data from the CDC WONDER database. Institutional Review Board (IRB) approval and informed consent were not required in accordance with the Common Rule.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This manuscript does not contain any individual person\u2019s data in any form.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"258"}}